{
  "id": 11040955,
  "title": "SERD Combination Slows Breast Cancer After CDK4/6 Inhibitor Progression",
  "url": "https://urgent.news/2026/09/30/serd-combination-slows-breast-cancer-after-cdk4-6-inhibitor",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-30T21:32:37.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/breastcancer/123209"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- An all-oral treatment regimen for advanced estrogen receptor (ER)-positive breast cancer almost doubled progression-free survival (PFS) versus standard endocrine therapy in a study of post-CDK4/6 progression disease. Among patients...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}